S
stinkcat_14
Guest
While certainly there is huge risk involved involved in drug research, just look at Pfizer, it’s stock is tanking because investors are worried that its pipeline of patent controlled drugs is drying up.If they produce drugs and oil and IF their revenues are higher than their expenses, then the difference is their profit.
There is a problem in the drug research field though and that has to do with FDA approvals. When the FDA approves a new drug, it only requires the drug to demonstrate that it is more effective than the placebo, not whether the drug is more effective than what is currently available on the market.
I was talking to a dermatologist and he was telling me about a drug Solodyn, an expensive version of Minocycline. It sells for about $15 per pill. Generic minocycline is less than $1 per pill. He has no way of knowing whether the new pill is really worth $14 more per pill. Of course, the new pill has plenty of sales reps offering goodies to get doctors to prescribe it, nobody is pushing the generic though.